
Kainos Curatives Private Limited
About Kainos Curatives Private Limited
Data last updated:
Kainos Curatives Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC281488. Its GSTIN is 36AAGCK1725M1ZC (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹52 Lakh. It is led by directors Mary Jayapradha Reddy Vannala and Ravuri Udaya Lakshmi.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # 1039 & 1040 Sector – 7 Koper Khairane, Navi Mumbai, Maharashtra, India – 400709.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.83 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹36.35 Lakh (net margin 7.5%) and EBITDA of ₹59.82 Lakh (EBITDA margin 12.4%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 9% over five years.
The company has about 39 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kainos Curatives Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address# 1039 & 1040 Sector – 7 Koper Khairane, Navi Mumbai, Maharashtra, India – 400709
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kainos Curatives Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kainos Curatives is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Kainos Curatives Private Limited, buy the company report.
Financials of Kainos Curatives Private Limited
FY 2025 filings availableKainos Curatives Private Limited reported revenue of ₹4.83 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 9% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹59.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹36.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.4% | ||||
| Net Profit Margin | 7.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kainos Curatives Private Limited, buy the company report.
Board of directors of Kainos Curatives Private Limited
Kainos Curatives has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mary Jayapradha Reddy Vannala | Director | 23 May 2016 | 10 Years 5 Months | Current |
| Ravuri Udaya Lakshmi | Director | 23 May 2016 | 10 Years 5 Months | Current |
Auditor
Kainos Curatives Private Limited is audited by K Bhaskar & Associates for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K Bhaskar & Associates | FY 2019 | 020817S |
Shareholding
The shareholding of Kainos Curatives Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Kainos Curatives Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kainos Curatives Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kainos Curatives Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kainos Curatives Private Limited has a workforce of 39 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Kainos Curatives has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCK1725M1ZC | Telangana | Active | 01 Jul 2017 |
| 37AAGCK1725M1ZA | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kainos Curatives Private Limited, buy the company report.
Recent activity
Kainos Curatives Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Mary Jayapradha Reddy Vannala was appointed as Director on 23 May 2016.
Frequently asked questions
Kainos Curatives is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 May 2016 (10+ years old) and is registered under CIN U74999MH2016PTC281488.
Kainos Curatives has 2 current directors:
- Mary Jayapradha Reddy Vannala - Director
- Ravuri Udaya Lakshmi - Director
The latest financial statements of Kainos Curatives on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Kainos Curatives is 36AAGCK1725M1ZC, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAGCK1725M1ZA (Andhra Pradesh).
The CIN (Corporate Identification Number) of Kainos Curatives is U74999MH2016PTC281488. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kainos Curatives was incorporated on 23 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Mary Jayapradha Reddy Vannala was appointed as Director on 23 May 2016. Ravuri Udaya Lakshmi was appointed as Director on 23 May 2016.
The registered office of Kainos Curatives is at # 1039 & 1040 Sector – 7 Koper Khairane, Navi Mumbai, Maharashtra, India – 400709.
Kainos Curatives operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Kainos Curatives is compliant as of 16 September 2026. The company is actively filing with the Registrar of Companies.

